Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Jill Alldredge

Concepts (55)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Uterine Cervical Neoplasms
2
2023
268
0.970
Why?
Endogenous Retroviruses
1
2023
37
0.730
Why?
Uterine Neoplasms
2
2021
98
0.720
Why?
Ovarian Neoplasms
3
2022
596
0.620
Why?
Papillomavirus Infections
1
2023
344
0.560
Why?
Germ-Line Mutation
1
2019
177
0.530
Why?
Genital Neoplasms, Female
1
2019
99
0.520
Why?
Programmed Cell Death 1 Receptor
1
2019
266
0.510
Why?
B7-H1 Antigen
1
2019
244
0.510
Why?
Angiogenesis Inhibitors
1
2016
239
0.410
Why?
Neoplasm Recurrence, Local
2
2023
1150
0.410
Why?
Early Detection of Cancer
1
2019
486
0.400
Why?
Immunohistochemistry
2
2019
1723
0.220
Why?
Choriocarcinoma
1
2022
9
0.190
Why?
Endodermal Sinus Tumor
1
2022
10
0.190
Why?
Adenocarcinoma, Mucinous
1
2022
76
0.170
Why?
Neoplasms, Germ Cell and Embryonal
1
2022
76
0.170
Why?
Genetic Counseling
1
2019
80
0.140
Why?
DNA Mutational Analysis
1
2019
410
0.130
Why?
RNA
1
2023
912
0.120
Why?
Cyclohexanes
1
2016
22
0.120
Why?
Survival Analysis
1
2019
1378
0.120
Why?
Perineum
1
2016
37
0.120
Why?
Sesquiterpenes
1
2016
52
0.120
Why?
Genetic Testing
1
2019
483
0.120
Why?
Obstetric Labor Complications
1
2016
38
0.120
Why?
Metabolomics
1
2021
733
0.110
Why?
Lacerations
1
2016
40
0.110
Why?
Urinary Incontinence
1
2016
65
0.110
Why?
Neoplasm Staging
1
2019
1475
0.110
Why?
Bevacizumab
1
2016
168
0.110
Why?
Sexual Dysfunction, Physiological
1
2016
75
0.110
Why?
Female
7
2023
79045
0.100
Why?
Neoplasm Metastasis
1
2016
688
0.100
Why?
Clinical Trials as Topic
1
2016
1062
0.080
Why?
Genetic Predisposition to Disease
1
2019
2399
0.080
Why?
Humans
7
2023
145783
0.070
Why?
Prognosis
1
2016
4330
0.060
Why?
Middle Aged
3
2022
36309
0.050
Why?
Carcinoma, Endometrioid
1
2022
49
0.050
Why?
Carboplatin
1
2021
164
0.040
Why?
Paclitaxel
1
2021
259
0.040
Why?
Cisplatin
1
2021
345
0.040
Why?
Drug Resistance, Neoplasm
1
2021
883
0.030
Why?
Labor, Obstetric
1
2016
68
0.030
Why?
Fecal Incontinence
1
2016
90
0.030
Why?
Postpartum Period
1
2016
373
0.020
Why?
Adult
3
2022
40881
0.020
Why?
Young Adult
2
2021
14254
0.020
Why?
Antineoplastic Combined Chemotherapy Protocols
1
2021
1969
0.020
Why?
Aged, 80 and over
1
2021
8347
0.020
Why?
Prospective Studies
1
2016
8078
0.010
Why?
Surveys and Questionnaires
1
2016
6085
0.010
Why?
Pregnancy
1
2016
7216
0.010
Why?
Aged
1
2021
26217
0.010
Why?
Alldredge's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)